Nurten Sayin Ekinci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nurten Sayin Ekinci has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Habibe Sema Arslan
Kirsehir Ahi Evran Universitesi
2 shared publications - Bulent Aydinli
Akdeniz University Faculty of Medicine, Department of General Surgery, Antalya, Türkiye
1 shared publication - Burcu Karakus Turan
Akdeniz University School of Medicine, Departmant of Medical Biology and Genetics, Antalya, Turkey
1 shared publication - Fahri Ucar
Department of Medical Biology and Genetics, School of Medicine, Akdeniz University, Antalya, Turkey.
1 shared publication - Huseyin Kocak
Medical Faculty, Department of Nephrology, Akdeniz University, Dumlupınar bulvarı, Akdeniz Üniversitesi Hastanesi, Arapsuyu, 07059, Antalya, Turkey
1 shared publication - Sule Darbaş Aras
Akdeniz University School of Medicine, Departmant of Medical Biology and Genetics, Antalya, Turkey
1 shared publication
Latest Publications
- Open Access
- 15 November 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (4) , 243-253
Determination of HLA Tissue Type According to the Etiology of Patients with Chronic Renal Failure
Chronic kidney disease (CKD) is a prominent public health concern, is defined as functional and structural damage to the kidneys. This study aims to investigate the association between human leukocyte antigen (HLA) alleles individuals with CKD and the different etiological subgroups of diesease. Genomic DNA was obtained from peripheral blood samples of 1,079 patients with retrospective CKD and 1,111 healthy control individuals. HLA genotyping was conducted using the Luminex based low-resolution method. Allele frequency distributions were calculated with the help of Arlequin v3.11 population genetics statistics program and SPSS v23.0 program, and p<0.05 values were accepted as significant by chi-square tests. HLA A*02 (21.83%), B*35 (18.30%), DRB1*11 (21.41%) alleles were observed most frequently in individuals with CKD, respectively. In our study, B*08, B*49, B*50 alleles in the HLA B locus (p=0.002, p=0.012 p=0.009) and DRB1*03, *04 alleles in the HLA DRB1 locus (p<0.001, p<0.001) were found positively associated with CKD. A*02, A*11, A*74 alleles at the HLA A locus (p=0.003, p<0.001, p=0.009) and B*27, B*39, B* alleles at the HLA B locus 40, B*59 (p<0.001, p<0.001, p<0.001, p=0.009), DRB1*07, *08, *09, *13, *16 (p<0.001, p=0.012, p=0.007, p<0.001, p<0.001) alleles were determined as negatively associated with the disease. Among the etiological groups of CKD, cystic kidney disease (36.8%), hypertension (16.8%) and urological anomalies (16.6%) were negatively associated with the HLA-DR*13 allele. Since CKD shows serious morbidity and mortality, this comprehensive study of HLA subgroups gave an explanatory idea about which alleles associated with the disease in terms of susceptibility and protection.
- 15 November 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (4) , 243-253
Open AccessDetermination of HLA Tissue Type According to the Etiology of Patients with Chronic Renal Failure
Chronic kidney disease (CKD) is a prominent public health concern, is defined as functional and structural damage to the kidneys. This study aims to investigate the association between human leukocyte antigen (HLA) alleles individuals with CKD and the different etiological subgroups of diesease. Genomic DNA was obtained from peripheral blood samples of 1,079 patients with retrospective CKD and 1,111 healthy control individuals. HLA genotyping was conducted using the Luminex based low-resolution method. Allele frequency distributions were calculated with the help of Arlequin v3.11 population genetics statistics program and SPSS v23.0 program, and p<0.05 values were accepted as significant by chi-square tests. HLA A*02 (21.83%), B*35 (18.30%), DRB1*11 (21.41%) alleles were observed most frequently in individuals with CKD, respectively. In our study, B*08, B*49, B*50 alleles in the HLA B locus (p=0.002, p=0.012 p=0.009) and DRB1*03, *04 alleles in the HLA DRB1 locus (p<0.001, p<0.001) were found positively associated with CKD. A*02, A*11, A*74 alleles at the HLA A locus (p=0.003, p<0.001, p=0.009) and B*27, B*39, B* alleles at the HLA B locus 40, B*59 (p<0.001, p<0.001, p<0.001, p=0.009), DRB1*07, *08, *09, *13, *16 (p<0.001, p=0.012, p=0.007, p<0.001, p<0.001) alleles were determined as negatively associated with the disease. Among the etiological groups of CKD, cystic kidney disease (36.8%), hypertension (16.8%) and urological anomalies (16.6%) were negatively associated with the HLA-DR*13 allele. Since CKD shows serious morbidity and mortality, this comprehensive study of HLA subgroups gave an explanatory idea about which alleles associated with the disease in terms of susceptibility and protection.